VBI Vaccines traded mostly under the radar over the last couple of years. The recent developments in the drug pipeline provide catalysts for the stock. A hepatitis B vaccine candidate for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback